Cytopenic overt primary myelofibrosis at presentation: Analysis of outcomes in the prospective, real‐world ERNEST‐2 registry
Paola Guglielmelli(Azienda Ospedaliero-Universitaria Careggi), Tiziano Barbui(University of Bergamo), Alessandra Carobbio(Ospedale Papa Giovanni XXIII), Maria Chiara Finazzi(Ospedale Papa Giovanni XXIII), Daniele Vanni(Istituti di Ricovero e Cura a Carattere Scientifico), Alessandro M. Vannucchi(Azienda Ospedaliero-Universitaria Careggi), Arianna Masciulli(Ospedale Papa Giovanni XXIII), Ana Triguero(Hospital Clínic de Barcelona), Björn Andréasson(NU Hospital Group), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Arianna Ghirardi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Elisa Rumi(University of Pavia), Helna Pettersson(NU Hospital Group), Valentina Boldrini(Azienda Ospedaliero-Universitaria Careggi), Barbara Mora(Casa Sollievo della Sofferenza), Alberto Álvarez‐Larrán(Hospital Clínic de Barcelona), Lucrezia Morrone(Azienda Ospedaliero-Universitaria Careggi), Francesco Passamonti(University of Milan)
Cited by 1
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k